The Valley Desk

NCT04895436 · Interventional trial

Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)

Overall registry status Recruiting

Phase 2

Conditions Chronic Lymphocytic Leukemia (CLL)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov